Home Markets Q32 Bio: Oppenheimer slashes price target on mixed trial results

Q32 Bio: Oppenheimer slashes price target on mixed trial results

Andrew M Dec 11, 2024 comments off

Original source: https://www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target–on-mixed-trial-results-3765273

Bio Therapeutic Drugs Market Updates Q32 BIO www.investing.com/news/stock-market-news/q32-bio-oppenheimer-slashes-price-target--on-mixed-trial-results-3765273